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Introduction arterial embolus at the territory of the superficial
femoral artery to the right leg. There was otherwise
Factor V (FV) Leiden, an autosomal dominant gene no evidence of peripheral vascular disease at the
mutation, is recognised as the commonest familial extremities. Examination of the heart, chest and ab-
thrombophilic disorder. It affects up to 7% of the domen was unremarkable. Full blood count, clotting
European population and is associated with 40 to 60% profile, urea and electrolytes, and liver function test
of patients who present with deep venous throm- were normal. ESR was 25 mm/h. Both ECG and chest
bosis.1,2 Although the association of FV Leiden with X-ray failed to show any abnormalities.
venous thromboembolism is well established, sig- At urgent embolectomy extensive thrombosis was
nificant correlation of FV Leiden with arterial thrombo- removed from the right leg. The procedure was un-
embolism remains inconclusive. We report a patient eventful and unfractionated heparin was infused at
presenting with recurrent arterial thromboembolism 1000 IU/hour, with APTT ratio maintaining at 2.0.
which eventually necessitated bilateral amputation of Four days later, the patient complained of increasing
the lower extremities. An intensive radiological search right leg pain, together with paraesthesia and mottling
failed to identify the source of embolus. However, at the left leg. Physical examination showed an absent
thrombophilic screen revealed FV Leiden as the sole femoral pulse on both legs. Emergency exploration of
prothrombotic factor. both femoral arteries revealed extensive thrombosis.
Despite multiple embolectomies with intraluminal re-
combinant tissue–plasminogen activator and heparin
infusion, together with venous bypass autograftCase Report
(which recurrently thrombosed during the procedure)
in an attempt to re-establish the circulation, neitherA 61-year-old housewife, non-smoker, of Irish origin
presented with a 2-hour history of an acutely painful leg could be salvaged. A right above-knee and a left
ischaemic right leg. The patient was on no medication. below-knee amputation were performed. Trans-
Apart from a history of possible rheumatic fever con- oesophageal echocardiogram, concomitant with digital
tracted at childhood, the past medical history, together vascular imaging and CT scan to the aorta and iliac
with systemic enquiry, was unremarkable. There was arteries, failed to reveal any valvular or vascular lesion.
no relevant family history. Ultrasonography of the abdomen and pelvis did not
Physical examination was consistent with an acute show any abnormalities.
Subsequently, on the intensive care unit, the patient
developed a thrombosis of her right radial artery
* Please address all correspondence to: T. Ng, Dept of Haemato- secondary to an arterial line insertion. Despite ad-logical Medicine, King’s College Hospital, Denmark Hill, London
SE5 9RS, U.K. equate heparinisation, the patient developed ischaemic
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Fig. 1. Chronological events with respect to variation of platelet count.
changes in both amputated stumps. A left above- heparin-induced thrombocytopenia was made.
Heparin was replaced with Danaparoid infusion andknee amputation was performed because of irreparable
ischaemic damage. Twenty-four hours postoperatively, warfarin was commenced. The patient was slowly
rehabilitated and no further thromboembolism wasthe patient was thrombocytopenic (96·109/l) with
normal clotting profile. The platelet count was further recorded. Thrombophilic screen (Table 1) showed the
presence of FV Leiden gene defect with no otherreduced to 30·109/l after 4 days. A diagnosis of
prothrombotic factors.
Table 1. The thrombophilic assay showing the prothrombotic
factors studied.
Screening assays
Lupus anticoagulant : negative Discussion
Anticardiolipin antibodies : negative
Protein C : 127 IU/dl {normal: 70 to 130 IU/dl}
Protein S (free antigen) : 65 IU/dl {normal: 26 to 64 IU/dl} The molecular defect of FV Leiden (Arg506Gln), which
Anti-thrombin III : 71 IU/dl (when fully heparinised) accounts for up to 90% of activated protein C re-
: 89 IU/dl (when fully warfarinised)
sistance, is commonly assessed by a modified APTT-{normal: 80 to 120 IU/dl}
Activated protein C ratio : 1.6 {normal >2.1} based assay with the result expressed as a ratio (APCR)
(APCR) [result suggesting the presence of which produces a sensitivity and specificity close to
FV Leiden]
DNA analysis.3 Heparin-induced arterial thrombosis, aHomocysteine level : 9.4 lmol/l {normal <17 lmol/l}
Random cholesterol : 4.8 mmol/l recognised but very uncommon complication, usually
DNA analysis occurs at least 4 days after the initiation of heparin
Factor V Leiden (Arg506Gln) : present [heterozygous] and is commonly associated with significant thrombo-
Prothrombin variant (G20210A) : negative
cytopenia.4 It may be implicated as a possible cause
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